Risky choices link the subthalamic nucleus with pathological gambling in Parkinson's disease

Movement Disorders

Volumn 28, Issue 12, 2013, Pages 1617-1619

  Jahanshahi, Marjan ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

BRAIN DEPTH RECORDING; BRAIN DEPTH STIMULATION; DECISION MAKING; EDITORIAL; EXECUTIVE FUNCTION; HIGH RISK BEHAVIOR; HUMAN; IMPULSIVENESS; NEGATIVE FEEDBACK; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; POSITIVE FEEDBACK; PRIORITY JOURNAL; RISK ASSESSMENT; SUBTHALAMIC NUCLEUS; TASK PERFORMANCE;

DECISION MAKING; FEMALE; GAMBLING; HUMANS; MALE; MEMBRANE POTENTIALS; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS;

EID: 84886395780     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25539     Document Type: Editorial

References (29)

1. Evenden JL. Varieties of impulsivity. Psychopharmacology 1999;146:348-361.
2. Dalley JW, Everitt B Robbins TW. Impulsivity, compulsivity, and top-down cognitive control. Neuron 2011;69:680-693.
3. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross sectional study of 3090 patients. Arch Neurol 2010;67:589-595.
4. Steeves TDL, Miyasaki JM, Zurowski M, et al. Increased striatal dopamine release in parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 2009;132:1376-1385.
5. van Eimeren T, Pellecchia G, Cilia R, et al. Drug induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology 2010;5:1-6.
6. van Eimeren T, Ballanger B, Pellecchia G, Miyasaki JM, Lang AE, Strafella AP. Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease? Neuropsychopharmacology 2009;34:2758-2766.
7. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908.
8. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362:2077-2091.
9. Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301:63-73.
10. Williams A, Gill S, Varma T, et al Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010;9:581-591.
11. Frank MJ. Hold your horses: a dynamic computational role for the subthalamic nucleus in decision making. Neural Netw 2006;19:1120-1136.
12. Jahanshahi M, Ardouin CM, Brown RG, et al. The impact of deep brain stimulation on executive function in Parkinson's disease. Brain 2000;123(pt 6):1142-1154.
13. Thobois S, Hotton GR, Pinto S, et al. STN stimulation alters pallidal-frontal coupling during response selection under competition. J Cereb Blood Flow Metab 2007;27:1173-1184.
14. Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007;318:1309-1312.
15. Coulthard EJ, Bogacz R, Javed S, Mooney LK, Murphy G, Keeley S, Whone AL. Distinct roles of dopamine and subthalamic nucleus in learning and probabilistic decision making. Brain 2012;135:3721-3734.
16. Zaghloul KA, Weidemann CT, Lega BC, Jaggi JL, Baltuch GH, Kahana MJ. Neuronal activity in the human subthalamic nucleus encodes decision conflict during action selection. J Neurosci 2012;32:2453-2460.
17. Hershey T, Revilla FJ, Wernle A, Gibson PS, Dowling JL, Perlmutter JS. Stimulation of STN impairs aspects of cognitive control in PD. Neurology 2004;62:1110-1114.
18. Ballanger B, van Eimeren T, Moro E, et al. Stimulation of the subthalamic nucleus and impulsivity: release your horses. Ann Neurol 2009;66:817-824.
19. Ray NJ, Jenkinson N, Brittain J, et al. The role of the subthalamic nucleus in response inhibition: evidence from deep brain stimulation for Parkinson's disease. Neuropsychologia 2009;47:2828-2834.
20. Wylie SA, Ridderinkhof KR, Elias WJ, et al. Subthalamic nucleus stimulation influences expression and suppression of impulsive behaviour in Parkinson's disease. Brain 2010;133(pt 12):3611-3624.
21. Rosa M, Fumagalli M, Giannicola G, et al. Pathological gambling in Parkinson's disease: subthalamic oscillations during economics decisions. Mov Disord 2013;28:1644-1652.
22. Rodriguez-Oroz, MC, Lopez-Azcarate J, Garcia-Garcia J, et al. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. Brain 2011:134;36-49.
23. Cavanagh JF, Wiecki TV, Cohen MX, et al. Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold. Nature Neurosci 2011;14:1462-1467.
24. Fumagalli M, Giannicola G, Rosa M, et al. Conflict-dependent dynamic of subthalamic nucleus oscillations during moral decisions. Soc Neurosci 2011;6:243-256.
25. Lim SY, O'Sullivan SS, Kotschet K, et al. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. J Clin Neurosci 2009;16:1148-1152.
26. Halbig TD, Tse W, Frisina PG, et al. Subthalamic deep brain stimulation and impulse control in Parkinson's disease. Eur J Neurol 2009;16:493-497.
27. Voon V, Krack P, Lang AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008, 131:2720-2728.
28. Baunez C, Dias C, Cador M, Amalric M. The subthalamic nucleus exerts opposite control on cocaine and "natural" rewards. Nat Neurosci 2005;8:484-489.
29. Uslaner JM, Yang P, Robinson TE. Subthalamic nucleus lesions enhance the psychomotor-activating, incentive motivational, and neurobiological effects of cocaine. J Neurosci 2005;25:8407-8415.